Search | Proceedings | Concurrent Oral Session Grid | Author Index | eBook

Author Index: W

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Wagner, L. I.
P4-27   INTEGRATING THE PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS) SYMPTOM ASSESSMENT INTO ROUTINE CANCER CARE
Wang, E.
P4-40   DO VALID FILM DECISION-AIDS INFORM PARENTS ON POTENTIAL OUTCOMES OF EXTREME PREMATURITY WITHOUT CREATING STRESS?
Wang, G.
P4-4   COSTS OF ACUTE MYOCARDIAL INFARCTION HOSPITALIZATIONS FOR PATIENTS AGED 18-64 YEARS IN THE UNITED STATES
Wang, Y.
I-4   CALIBRATION METHODS FOR INFERRING TRANSITION PROBABILITIES FROM CROSS-SECTIONAL STUDIES
Warholak, T. L.
P3-30   ASSESSING HEALTHCARE PROVIDER SATISFACTION OF SERVICES PROVIDED BY THE ARIZONA REGIONAL EXTENSION CENTER (REC): A CROSS-SECTIONAL SURVEY
Warren, J. L.
P1-44   OPPORTUNITIES AND CHALLENGES IN USING ADMINISTRATIVE DATA FOR CROSS-COUNTRY COMPARISONS OF HEALTH CARE COSTS
Wasil, E.
P2-34   LONG DISTANCE TRIAGE: ASSESSING PATIENT RISK FOR INTER-HOSPITAL TRANSFER PATIENTS
Waycaster, C.
P1-14   A COST-EFFECTIVENESS ANALYSIS COMPARING TWO ALTERNATIVE DEBRIDEMENT THERAPIES FOR NECROTIC PRESSURE ULCERS IN A LONG-TERM CARE SETTING,
P3-26   THE COST-EFFECTIVENESS OF BECAPLERMIN WHEN USED AS AN ADJUNCT THERAPY WITH GOOD DIABETIC FOOT ULCER CARE
Weber, E.
P2-23   HOW PATIENTS DISCUSS RISKS: WORDS AND NUMBERS
Weber, T. A.
E-1   OPTIMAL INFORMATION ACQUISITION POLICY IN DYNAMIC HEALTHCARE POLICY: APPLICATION TO HCV SCREENING,
I-6   OPTIMAL HEALTH PROGRAM INTERVENTION AND INFORMATION ACQUISITION POLICY
Wei, W.
H-2   META-ANALYSIS OF REAL-WORLD STUDIES OF INITIATING INSULIN GLARGINE VIA DISPOSABLE PEN VERSUS VIAL/SYRINGE AMONG PATIENTS WITH TYPE 2 DIABETES: APPLYING A COMMON DATA STRUCTURE TO A UNIQUE EVIDENCE SYNTHESIS PLATFORM
Weinstein, A. L.
P3-51   PATIENT DISCORDANCE BETWEEN SURGERY CHOICE AND TREATMENT-RELATED VALUES: A PRELIMINARY STUDY OF BARIATRIC PATIENTS
Weinstein, M. C.
L-3   COMPARING FIFTEEN APPROACHES OF ASSESSING CARDIOVASCULAR DISEASE RISK USING RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE ANALYSIS,
L-5   COST-EFFECTIVENESS OF SCREENING RESISTANT HYPERTENSIVE PATIENTS FOR PRIMARY ALDOSTERONISM,
P1-5   THE ECONOMIC BURDEN OF CHILDHOOD AUTISM SPECTRUM DISORDERS,
P1-19   EFFECTS OF DECISION AMBIGUITY AND CONFLICTS OF INTEREST ON PERCEIVED VALUE OF A MEDICAL SERVICE,
P3-47   PARENT AND CHILD HEALTH UTILITIES ASSOCIATED WITH AUTISM SPECTRUM DISORDERS
Weir, S.
TRA2-3   THE EFFECT OF PREHOSPITAL PROVIDER TRIAGE ACCURACY ON THE COST-EFFECTIVENESS HELICOPTER SCENE TRANSPORT FOR TRAUMA
Weis, L.
P3-15   WHEN DO PHYSICIANS RECOMMEND JOINT REPLACEMENT FOR PATIENTS WITH MODERATE DISEASE?
Wells, B. J.
P2-5   THE COST-EFFECTIVENESS OF SULINDAC-DIFLUOROMETHYLORNITHINE FOR THE PREVENTION OF COLORECTAL CANCER
Wentink, M. M.
P4-20   BARRIERS AND FACILITATORS TO IMPLEMENT SHARED DECISION MAKING IN TREATMENT OF SCIATICA PATIENTS
Werle, J.
K-6   COST-EFFECTIVENESS OF METAL-ON-METAL HIP RESURFACING COMPARED TO CONVENTIONAL TOTAL HIP ARTHROPLASTY
Wexler, R.
P3-1   THE IMPLEMENTATION OF PATIENT DECISION SUPPORT INTERVENTIONS INTO ROUTINE CLINICAL PRACTICE: A SYSTEMATIC REVIEW
Wexler, R.
D-3   CAN A DASHBOARD BE USED TO MONITOR INFORMED PATIENT CHOICE?
Whitehead, N.
P2-22   A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5   REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION
Whitehurst, D. G.
B-3   ASK A DIFFERENT QUESTION, GET A DIFFERENT ANSWER: ISOLATING THE INFLUENCE OF VARIATION IN THE DESCRIPTIVE SYSTEMS OF THE EQ-5D AND SF-6D
Whitelaw, W. A.
P1-29   PHYSICIAN OVERUTILIZATION OF SLEEP STUDIES IN PREDICTING PATIENT IMPROVEMENT USING CPAP
Widmer, C. L.
D-2   AN INTELLIGENT TUTORING SYSTEM TO HELP WOMEN DECIDE ABOUT TESTING FOR GENETIC BREAST CANCER RISK,
P1-48   MULTIPLE SIGNAL DETECTION APPLIED TO GIST-BASED DISCRIMINATION OF GENETIC RISK IN BREAST CANCER
Wiener, S.
P3-7   CENTERING PREGNANCY FOR THE PREVENTION OF PRETERM BIRTH: A COST-EFFECTIVENESS ANALYSIS
Wilkie, M.
D-1   TESTING THE ADDED VALUE OF DECISION AID COMPONENTS TO FACILITATE PATIENTS INFORMED DECISION MAKING ABOUT DIALYSIS TREATMENT OPTIONS
Wilkins, T.
F-6   USING SIMULATED DATA TO VALIDATE BAYESIAN MIXED TREATMENT COMPARISON META-ANALYSIS FOR DIFFERENT EVIDENCE NETWORK PATTERNS AND NUMBERS OF STUDIES
Wilson, K.
P4-26   UTILIZATION OF USTEKINUMAB IN BIOLOGIC-EXPERIENCED AND BIOLOGIC-NAïVE PSORIASIS PATIENTS
Wilson, L. S.
P4-8   A PROSECTIVE STUDY ON COSTS TO INSURANCE AND OUT-OF-POCKET COSTS OF COCHLEAR IMPLANTATION COMPARED WITH HEARING AIDS IN NEWLY IMPLANTED ADULT RECIPIENTS
Winterbottom, A.
D-1   TESTING THE ADDED VALUE OF DECISION AID COMPONENTS TO FACILITATE PATIENTS INFORMED DECISION MAKING ABOUT DIALYSIS TREATMENT OPTIONS
Witteman, H. O.
G-1   BLOCKS, OVALS, OR PEOPLE: DOES ICON TYPE IN PICTOGRAPHS INFLUENCE THE CORRELATION BETWEEN PERCEIVED AND ACTUAL RISK?,
J-2   HOLD MY HAND: EXPLICITLY SHOWING TRADEOFFS AND FIT BETWEEN VALUES AND OPTIONS HELPS PEOPLE MAKE CHOICES CONCORDANT WITH THEIR STATED VALUES
Wittenberg, E.
J-4   MEASURING FAMILY HRQOL SPILLOVER EFFECTS USING DIRECT HEALTH UTILITY ASSESSMENT,
P3-11   HOW ILLNESS AFFECTS FAMILY MEMBERS: DOMAINS OF WELL-BEING AFFECTED BY “SPILLOVER”,
P4-16   THE IMPACT OF CURRENT ILLICIT DRUG USE ON QUALITY OF LIFE IN HIV INFECTED AND AT RISK WOMEN: IMPLICATIONS FOR COMBINED HEALTH UTILITIES
Wittenborn, J.
P1-8   THE VALUE OF INFORMATION OF ADDITIONAL RESEARCH REGARDING BIRTH-COHORT SCREENING FOR HEPATITIS C,
P1-57   ESTIMATING THE EXPECTED VALUE OF PERFECT PARAMETER INFORMATION (EVPPI): APPLICATIONS OF SHORT-CUT ALGORITHMS
Wittink, M.
P4-35   PATIENT CHARACTERISTICS ASSOCIATED WITH PREFERENCE PATTERNS AND MESSAGING FRAMES FOR DEPRESSION TREATMENT
Wodchis, W.
P2-1   COST-EFFECTIVENESS OF STROKE PREVENTION THERAPIES IN ATRIAL FIBRILLATION PATIENTS: A NEW GENERATION OF DRUGS
Wolf, A. M. D.
D-5   NOVEL METHODS TO OVERCOME HEALTH LITERACY BARRIERS TO SHARED DECISION MAKING IN PROSTATE CANCER AMONG LOW-INCOME AFRICAN AMERICAN MEN
Wolfe, C. R.
D-2   AN INTELLIGENT TUTORING SYSTEM TO HELP WOMEN DECIDE ABOUT TESTING FOR GENETIC BREAST CANCER RISK,
P1-48   MULTIPLE SIGNAL DETECTION APPLIED TO GIST-BASED DISCRIMINATION OF GENETIC RISK IN BREAST CANCER
Wolfe, F.
P1-3   IMPLICATIONS OF USING EFFECTIVENESS INSTEAD OF EFFICACY ON THE COST-EFFECTIVENESS OF BIOLOGICS IN RHEUMATOID ARTHRITIS: A MULTI-STUDY SENSITIVITY ANALYSIS
Wong, J.
P1-6   COST-EFFECTIVENESS ANALYSIS OF NEW DIRECT-ACTING ANTIVIRALS (DAAS) THERAPY FOR PATIENTS WITH UNTREATED CHRONIC HEPATITIS C GENOTYPE 1 INFECTION IN THE VETERANS HEALTH ADMINISTRATION
Wong, W. W. L.
P2-52   A PARALLEL SLIDING REGION ALGORITHM TO MAKE AGENT-BASED MODELING POSSIBLE FOR LARGE-SCALE SIMULATION
Wong, W.
P3-49   USING RFID-BASED REAL-TIME LOCATION SYSTEMS TO DESCRIBE AND UNDERSTAND SOCIAL NETWORKS IN THE OUTPATIENT SETTING,
P3-50   EXPLORING USER RESISTANCE AND TECHNOLOGY ADOPTION FACTORS IN HEALTHCARE
Wright, D. R.
P1-50   SIMULATING COLLATERAL WEIGHT LOSS WITHIN SOCIAL NETWORKS: CAPITALIZING ON SPILLOVER EFFECTS TO IMPROVE HEALTH
Wright, E.
B-6   A RANDOMIZED CONTROLLED TRIAL OF TWO PRINCIPLES OF DIAGNOSTIC SUPPORT
Wu, J.
P1-38   IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON DISEASE BURDEN IN A CALIFORNIA MEDICAID POPULATION WITH COMORBID TYPE II DIABETES AND CARDIOVASCULAR DISEASE,
P4-18   DISCONTINUATION OF ORAL 5-AMINOSALICYLIC ACID THERAPY ASSOCIATED WITH INCREMENTAL ALL-CAUSE HEALTHCARE COSTS IN ACTIVE ULCERATIVE COLITIS PATIENTS
Wu, S.
P3-2   AN AUTOMATED TELEPHONIC SCREENING AND MONITORING SYSTEM FOR DEPRESSION CARE MANAGEMENT: PRELIMINARY FINDINGS FROM A CLINICAL TRIAL
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z